KYNTRA BIO, INC. Earnings Per Share (Basic)
KYNTRA BIO, INC. (KYNB) reported Earnings Per Share (Basic) of $2.96 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- KYNTRA BIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was $2.96.
- KYNTRA BIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$3.76, a 426.96% decline year-over-year.
- KYNTRA BIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was $49.61.
- KYNTRA BIO, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$1.88.
- KYNTRA BIO, INC. earnings per share, basic for fiscal 2025 was $45.37.
- KYNTRA BIO, INC. earnings per share, basic for fiscal 2024 was -$11.89.
- KYNTRA BIO, INC. earnings per share, basic for fiscal 2023 was -$2.92.
- KYNTRA BIO, INC. earnings per share, basic for fiscal 2022 was -$3.14.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.96 10-Q · filed 2026-08-13 | -$0.80 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$3.76 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | $45.37 10-K · filed 2026-03-16 | |||||||
| 2025-09-30 | $49.61 10-Q · filed 2025-11-10 | $48.90 10-Q · filed 2025-11-10 | ||||||
| 2025-06-30 | -$1.88 10-Q · filed 2026-08-13 | -$0.73 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | $1.15 10-Q · filed 2026-05-12 | $0.05 10-Q · filed 2025-05-12 | ||||||
| 2024-12-31 | -$11.89 10-K · filed 2026-03-16 | -$0.48 10-K · filed 2025-03-17 | ||||||
| 2024-09-30 | -$4.25 10-Q · filed 2025-11-10 | -$0.17 10-Q · filed 2024-11-12 | -$16.43 10-Q · filed 2025-11-10 | -$0.66 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | -$3.89 10-Q · filed 2025-08-11 | -$0.16 10-Q · filed 2024-08-06 | -$12.19 10-Q · filed 2025-08-11 | -$0.49 10-Q · filed 2024-08-06 | ||||
| 2024-03-31 | -$0.33 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | -$2.92 10-K · filed 2025-03-17 | |||||||
| 2023-09-30 | -$0.65 10-Q · filed 2024-11-12 | -$2.35 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | -$0.90 10-Q · filed 2024-08-06 | -$1.71 10-Q · filed 2024-08-06 | ||||||
| 2023-03-31 | -$0.81 10-Q · filed 2024-05-06 | |||||||
| 2022-12-31 | -$3.14 10-K · filed 2024-02-26 | |||||||
| 2022-09-30 | -$0.98 10-Q · filed 2023-11-06 | -$2.43 10-Q · filed 2023-11-06 | ||||||
| 2022-06-30 | -$0.78 10-Q · filed 2023-08-07 | -$1.46 10-Q · filed 2023-08-07 | ||||||
| 2022-03-31 | -$0.68 10-Q · filed 2023-05-08 | |||||||
| 2021-12-31 | -$3.14 10-K · filed 2024-02-26 | |||||||
| 2021-09-30 | $0.54 10-Q · filed 2022-11-07 | -$1.69 10-Q · filed 2022-11-07 | ||||||
| 2021-06-30 | -$1.45 10-Q · filed 2022-08-08 | -$2.24 10-Q · filed 2022-08-08 | ||||||
| 2020-12-31 | -$2.11 10-K · filed 2023-02-27 | |||||||
| 2020-09-30 | $0.36 10-Q · filed 2021-11-09 | -$1.46 10-Q · filed 2021-11-09 | ||||||
| 2020-06-30 | -$0.95 10-Q · filed 2020-08-06 | -$1.84 10-Q · filed 2020-08-06 | ||||||
| 2019-09-30 | -$0.57 10-Q · filed 2020-11-05 | $0.24 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | $1.34 10-Q · filed 2020-08-06 | $0.82 10-Q · filed 2020-08-06 | ||||||
| 2018-09-30 | -$0.50 10-Q · filed 2019-11-12 | -$1.28 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | -$0.28 10-Q · filed 2019-08-08 | -$0.78 10-Q · filed 2019-08-08 | ||||||
| 2017-06-30 | -$0.48 10-Q · filed 2017-08-07 | -$0.99 10-Q · filed 2017-08-07 | ||||||
| 2016-06-30 | $0.39 10-Q · filed 2017-08-07 | -$0.06 10-Q · filed 2017-08-07 | ||||||
| 2015-06-30 | $0.95 10-Q · filed 2016-08-08 | $0.18 10-Q · filed 2016-08-08 | ||||||
| 2014-06-30 | $1.36 10-Q · filed 2015-08-13 | $0.74 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |